- Home
- ADPT vs PTRN Comparison
ADPT vs PTRN Comparison
Compare ADPT & PTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADPT | PTRN |
|---|---|---|
| Founded | 2009 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.0B |
| IPO Year | 2019 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ADPT | PTRN |
|---|---|---|
| Price | $15.41 | $12.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | $16.60 | ★ $19.89 |
| AVG Volume (30 Days) | ★ 3.0M | 826.4K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $252,754,000.00 | ★ $2,293,676,000.00 |
| Revenue This Year | $50.81 | $39.02 |
| Revenue Next Year | $1.17 | $24.87 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 42.57 | ★ 67.86 |
| 52 Week Low | $5.81 | $12.00 |
| 52 Week High | $20.76 | $20.10 |
Technical Indicators
Market Signals| Indicator | ADPT | PTRN |
|---|---|---|
| Relative Strength Index (RSI) | 44.33 | N/A |
| Support Level | $14.58 | N/A |
| Resistance Level | $16.26 | N/A |
| Average True Range (ATR) | 1.13 | 0.00 |
| MACD | -0.36 | 0.00 |
| Stochastic Oscillator | 13.75 | 0.00 |
Price Performance
Historical ComparisonAbout ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About PTRN Pattern Group Inc.
Pattern Group Inc is an ecommerce accelerator, uses its technology platform, data science and a team of experts to drive growth for brands. The Company acquires inventory from brand partners to sell to consumers, enabling full control over content, pricing, logistics and customer service. Brand partners that contract with the Company operate in various industries including health and wellness, beauty and personal care, home and lifestyle, pet, sports and outdoors and consumer electronics.